Latest filing published 07 Aug 2023 for Biocorp Production, €70.0M. Read the official filing
Not enough history yet: 0 closed purchases, at least 2 are needed.
Jacques Gardette (chief executive) discloses dealings in Biocorp Production to AMF. We count 2 filings; the first trade dates from 19 July 2022 and the latest from 4 August 2023.
On the open market, the record shows 1 purchase worth €75k and 1 sale worth €70.0M. Taken together, the sales exceed the purchases by €69.9M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2023: no purchases and 1 sale on the market.
On 7 August 2023 came the latest disclosure, an open-market sale for €70.0M in Biocorp Production. The last purchase on record was published on 21 July 2022, which is 1,549 days ago. These figures are compiled from regulatory filings published by AMF. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations